# PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.

> **NCT07053072** · PHASE1 · RECRUITING · sponsor: **West China Hospital** · enrollment: 9 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DRUG:** Low Dose PD-1 mRNA LNP Vaccine
- **DRUG:** High dose PD-1 mRNA LNP vaccines

## Key facts

- **NCT ID:** NCT07053072
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-23
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-30
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07053072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07053072, "PD-1 mRNA LNP Vaccine for Advanced Primary Hepatocellular Carcinoma.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07053072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*